The Prostate

Cover image for Vol. 75 Issue 11

August 1, 2015

Volume 75, Issue 11

Pages 1119–1226

  1. Review Articles

    1. Top of page
    2. Review Articles
    3. Original Articles
    1. The 21st Annual Prostate Cancer Foundation Scientific Retreat report (pages 1119–1128)

      Andrea K. Miyahira, Jonathan W. Simons and Howard R. Soule

      Article first published online: 20 APR 2015 | DOI: 10.1002/pros.22993

    2. Body mass index and mortality in men with prostate cancer (pages 1129–1136)

      Anna Cantarutti, Stephanie E. Bonn, Hans-Olov Adami, Henrik Grönberg, Rino Bellocco and Katarina Bälter

      Article first published online: 30 APR 2015 | DOI: 10.1002/pros.23001

  2. Original Articles

    1. Top of page
    2. Review Articles
    3. Original Articles
    1. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial (pages 1160–1166)

      Christopher M. Heaphy, Gaurav Gaonkar, Sarah B. Peskoe, Corinne E. Joshu, Angelo M. De Marzo, M. Scott Lucia, Phyllis J. Goodman, Scott M. Lippman, Ian M. Thompson Jr, Elizabeth A. Platz and Alan K. Meeker

      Article first published online: 20 APR 2015 | DOI: 10.1002/pros.22997

    2. Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer (pages 1167–1176)

      Sarah B. Peskoe, Corinne E. Joshu, Sabine Rohrmann, Katherine A. McGlynn, Sarah J. Nyante, Gary Bradwin, Adrian S. Dobs, Norma Kanarek, William G. Nelson and Elizabeth A. Platz

      Article first published online: 28 APR 2015 | DOI: 10.1002/pros.22998

    3. A randomized double-blind placebo controlled phase I–II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or “chemopromotion”? (pages 1177–1186)

      Paolo Gontero, Giancarlo Marra, Francesco Soria, Marco Oderda, Andrea Zitella, Francesca Baratta, Giovanna Chiorino, Ilaria Gregnanin, Lorenzo Daniele, Luigi Cattel, Bruno Frea and Paola Brusa

      Article first published online: 20 APR 2015 | DOI: 10.1002/pros.22999

    4. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor (pages 1187–1196)

      Yan Wang, Gaolei Liu, Dali Tong, Henna Parmar, Donald Hasenmayer, Wenqiang Yuan, Dianzheng Zhang and Jun Jiang

      Article first published online: 20 APR 2015 | DOI: 10.1002/pros.23000

    5. You have full text access to this OnlineOpen article
      A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer (pages 1206–1215)

      Dean A. Troyer, Tamara Jamaspishvili, Wei Wei, Ziding Feng, Jennifer Good, Sarah Hawley, Ladan Fazli, Jesse K. McKenney, Jeff Simko, Antonio Hurtado-Coll, Peter R. Carroll, Martin Gleave, Raymond Lance, Daniel W. Lin, Peter S. Nelson, Ian M. Thompson, Lawrence D. True, James D. Brooks and Jeremy A. Squire

      Article first published online: 4 MAY 2015 | DOI: 10.1002/pros.23003

    6. Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels (pages 1216–1226)

      Alba Font-Tello, Núria Juanpere, Silvia de Muga, Marta Lorenzo, José A. Lorente, Lluis Fumado, Laia Serrano, Sergio Serrano, Josep Lloreta and Silvia Hernández

      Article first published online: 4 MAY 2015 | DOI: 10.1002/pros.23004

SEARCH

SEARCH BY CITATION